Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04399941 · ClinicalTrials.gov registry record · NA

Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

A NA study of End Stage Renal Disease, sponsored by Boston Medical Center.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04399941: Recruiting NA study of End Stage Renal Disease, sponsored by Boston Medical Center.

NCT04399941 is a NA study of End Stage Renal Disease that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 50 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04399941, a NA study of End Stage Renal Disease, is actively recruiting participants, sponsored by Boston Medical Center.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central venous stenosis (CVS) and affects number of patients on hemodialysis in the United States and can compromise the dialysis efficacy. The current diagnostic modality for CVS is venography, which has several limitations. This study proposes to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will provide additional information.

Primary Outcome

The severity of venous stenosis will be assessed using venogram and IVUS results. It will be calculated as the percentage diameter or area reduction, expressed as the ratio of the MLD or MLA to the RVD or RVA.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Venography
  • DIAGNOSTIC_TEST Intravascular ultrasound (IVUS)
  • OTHER Image processing

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-08-03
Est. Completion 2026-09
Phase NA
Boston Medical Center

253 total trials

What NCT04399941 shows while recruiting

NCT04399941 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (94% lower).

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 3 interventions - of which Venography is the first listed.

NCT04399941 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04399941 about?

NCT04399941 is a clinical study titled "Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis". Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central veno...

What is the current status of trial NCT04399941?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-08-03. Estimated completion is 2026-09.

What conditions does trial NCT04399941 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT04399941?

The interventions under investigation include: Venography (DIAGNOSTIC_TEST), Intravascular ultrasound (IVUS) (DIAGNOSTIC_TEST), Image processing (OTHER).

Who is sponsoring clinical trial NCT04399941?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04399941 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04399941's enrollment target sits among peer trials

50 51st of 86 higher than 36 of 86 other End Stage Renal Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04399941, the US trial registry maintained by the National Library of Medicine. NCT04399941 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.